These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11682906)

  • 1. What's the difference between a pacemaker and an implantable cardioverter defibrillator (ICD)?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682906
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of new pacemaker and defibrillator technology.
    Shepard RB; Epstein AE; Kay GN
    Adv Card Surg; 1994; 5():181-208. PubMed ID: 8118592
    [No Abstract]   [Full Text] [Related]  

  • 3. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations of the Department of Arrhythmia and Clinical Electrophysiology (DAEC) of the Brazilian Cardiology Society on indications for permanent pacemaker implantation, choice of stimulation mode, and indications for automatic cardioverter-defibrillator implantation].
    Sosa EA; de Paola AA; Martinelli M; Costa R; Pimenta J; Lorga AM; Maia IG; d'Avila A; Halperin C
    Arq Bras Cardiol; 1995 Jun; 64(6):579-83. PubMed ID: 8561682
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pacemakers and defibrillators: what should we know about home monitoring?].
    Amara W; Sergent J
    Ann Cardiol Angeiol (Paris); 2006 Nov; 55(6):315-20. PubMed ID: 17191589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of implantable cardioverter defibrillator].
    Iturralde Torres P
    Arch Cardiol Mex; 2002; 72 Suppl 1():S86-90. PubMed ID: 12001878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of device therapy for ventricular arrhythmias.
    Holley LK
    Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac pacemaker and internal defibrillators (ICD). Basic principles and new important developments, status 1998].
    Deisenhofer I; Karch M; Zrenner B; Schmitt C; Schömig A
    Fortschr Med; 1998 Aug; 116(22-23):20-4, 26. PubMed ID: 9773595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous implantable cardioverter-defibrillator.
    Chang PM; Doshi R; Saxon LA
    Circulation; 2014 Jun; 129(23):e644-6. PubMed ID: 24914020
    [No Abstract]   [Full Text] [Related]  

  • 12. Should unipolar pacemaker leads be banned? Lessons from pacemaker/implantable cardioverter defibrillator interactions.
    Weiss DN; Zilo P; Luceri RM; Habal SM; David IB
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 1):237-9. PubMed ID: 9058859
    [No Abstract]   [Full Text] [Related]  

  • 13. Device sensing: sensors and algorithms for pacemakers and implantable cardioverter defibrillators.
    Kaszala K; Ellenbogen KA
    Circulation; 2010 Sep; 122(13):1328-40. PubMed ID: 20876446
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey.
    McDowell DL; Hauptman PJ
    J Heart Lung Transplant; 2009 Aug; 28(8):847-50. PubMed ID: 19632584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troubleshooting implantable cardioverter-defibrillator related problems.
    van Erven L; Schalij MJ
    Heart; 2008 May; 94(5):649-60. PubMed ID: 18411360
    [No Abstract]   [Full Text] [Related]  

  • 19. Nontransvenous implantable cardioverter defibrillator systems: not just for small pediatric patients.
    Kugler JD; Erickson CC
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):47-8. PubMed ID: 16426399
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.